Literature DB >> 21943786

Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems.

Lauren Branchini1, Caio V Regatieri, Ignacio Flores-Moreno, Bernhard Baumann, James G Fujimoto, Jay S Duker.   

Abstract

PURPOSE: To investigate the reproducibility of choroidal thickness measurements in normal subjects on 3 spectral domain optical coherence tomography (SD-OCT) instruments: Zeiss Cirrus HD-OCT (Carl Zeiss Meditec Inc., Dublin, CA), Heidelberg Spectralis (Heidelberg Engineering, Heidelberg, Germany), and Optovue RTVue (Optovue Inc., Fremont, CA).
DESIGN: Cross-sectional non-interventional study. PARTICIPANTS: Images were obtained in 28 eyes of 28 healthy undilated volunteers without ocular pathology in a clinical setting.
METHODS: All subjects were imaged on the fovea using Cirrus HD 1-line raster, Spectralis enhanced depth imaging (EDI), and RTVue retina-cross. MAIN OUTCOME MEASURES: The choroid was measured subfoveally, 750 μm temporal, and 750 μm nasal to the fovea. All measurements were performed by 2 independent observers. Two-way analysis of variance (ANOVA) with Bonferroni's post-test, Pearson correlation, and Bland-Altman analysis were used to compare measurements.
RESULTS: The group of 28 subjects consisted of 7 men and 21 women, with an average age of 35.2 years (range, 23-64 years). A 2-way ANOVA with Bonferroni's post-test revealed no significant difference in the average subfoveal choroidal thickness (P > 0.05) among systems for any location: subfoveally, 750 μm temporal, and 750 μm nasal to the fovea. The measurements of choroidal thickness from any pair of 3 instruments (Cirrus vs. Spectralis, Cirrus vs. RTVue, Spectralis vs. RTVue) were also strongly correlated. The Pearson correlation among all 2 system pairs of the 3 systems was greater than 0.9 (P < 0.0001). The 95% limits of agreement among 4 choroidal thickness measurements were +11.21% to -13.57% (bias -1.17) between Cirrus and RTVue, +10.85% to -12.45% (bias -0.80) between Spectralis and RTVue, and +12.81% to -13.33% (bias -0.25) between Cirrus and Spectralis.
CONCLUSIONS: In our population of young healthy adults with normal vision, there was good reproducibility among choroidal thickness measurements of images acquired with Cirrus, Spectralis, and RTVue. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21943786      PMCID: PMC3251715          DOI: 10.1016/j.ophtha.2011.07.002

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

Review 1.  Central serous chorioretinopathy: an update on pathogenesis and treatment.

Authors:  M Gemenetzi; G De Salvo; A J Lotery
Journal:  Eye (Lond)       Date:  2010-10-08       Impact factor: 3.775

2.  Enhanced depth imaging spectral-domain optical coherence tomography.

Authors:  Richard F Spaide; Hideki Koizumi; Maria C Pozzoni; Maria C Pozonni
Journal:  Am J Ophthalmol       Date:  2008-07-17       Impact factor: 5.258

3.  Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration.

Authors:  Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2009-01-18       Impact factor: 5.258

4.  Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Akira Ojima; Masashi Ogasawara; Richard F Spaide
Journal:  Ophthalmology       Date:  2010-05-15       Impact factor: 12.079

5.  Optical coherence tomography enhanced depth imaging of choroidal tumors.

Authors:  Virginia L L Torres; Nicole Brugnoni; Peter K Kaiser; Arun D Singh
Journal:  Am J Ophthalmol       Date:  2011-01-22       Impact factor: 5.258

6.  Cirrus HD-OCT high definition imaging is another tool available for visualization of the choroid and provides agreement with the finding that the choroidal thickness is increased in central serous chorioretinopathy in comparison to normal eyes.

Authors:  Varsha Manjunath; James G Fujimoto; Jay S Duker
Journal:  Retina       Date:  2010-09       Impact factor: 4.256

7.  Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Hiroshi Oyamada; Tetsuju Sekiryu; Takamitsu Fujiwara; Richard F Spaide
Journal:  Retina       Date:  2011-03       Impact factor: 4.256

8.  A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes.

Authors:  Ron Margolis; Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2009-02-20       Impact factor: 5.258

9.  Age-related choroidal atrophy.

Authors:  Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2009-02-20       Impact factor: 5.258

10.  Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.

Authors:  Ute E K Wolf-Schnurrbusch; Lala Ceklic; Christian K Brinkmann; Milko E Iliev; Manuel Frey; Simon P Rothenbuehler; Volker Enzmann; Sebastian Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

View more
  77 in total

Review 1.  Enhanced depth imaging-OCT of the choroid: a review of the current literature.

Authors:  H Laviers; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

2.  Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography.

Authors:  Jay Chhablani; Giulio Barteselli; Haiyan Wang; Sharif El-Emam; Igor Kozak; Aubrey L Doede; Dirk-Uwe Bartsch; Lingyun Cheng; William R Freeman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

3.  Assessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomography.

Authors:  Kaweh Mansouri; Felipe A Medeiros; Nicholas Marchase; Andrew J Tatham; Daniel Auerbach; Robert N Weinreb
Journal:  Ophthalmology       Date:  2013-09-08       Impact factor: 12.079

4.  Choroidal thickness measurements with optical coherence tomography in branch retinal vein occlusion.

Authors:  Muge Coban-Karatas; Rana Altan-Yaycioglu; Burak Ulas; Selcuk Sizmaz; Handan Canan; Cagla Sariturk
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 5.  Advances of optical coherence tomography in myopia and pathologic myopia.

Authors:  D S C Ng; C Y L Cheung; F O Luk; S Mohamed; M E Brelen; J C S Yam; C W Tsang; T Y Y Lai
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

6.  Feasibility of swept-source OCT for active birdshot chorioretinopathy.

Authors:  Olga Garcia-Garcia; Sara Jordan-Cumplido; Olaia Subira-Gonzalez; Pere Garcia-Bru; Luis Arias; Josep M Caminal-Mitjana
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-03       Impact factor: 3.117

7.  Identification and biometry of horizontal extraocular muscle tendons using optical coherence tomography.

Authors:  Guillermo Salcedo-Villanueva; Miguel Paciuc-Beja; Mariana Harasawa; Raul Velez-Montoya; Jeffrey L Olson; Scott C Oliver; Naresh Mandava; Hugo Quiroz-Mercado
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-03       Impact factor: 3.117

8.  Validation of Macular Choroidal Thickness Measurements from Automated SD-OCT Image Segmentation.

Authors:  Michael D Twa; Krystal L Schulle; Stephanie J Chiu; Sina Farsiu; David A Berntsen
Journal:  Optom Vis Sci       Date:  2016-11       Impact factor: 1.973

Review 9.  Optical coherence tomography--current and future applications.

Authors:  Mehreen Adhi; Jay S Duker
Journal:  Curr Opin Ophthalmol       Date:  2013-05       Impact factor: 3.761

10.  Topographic distribution features of the choroidal and retinal nerve fiber layer thickness in Chinese school-aged children.

Authors:  Wei-Qin Liu; Dan-Dan Wang; Xiao-Xia Yang; Yan-Yan Pan; Xue Song; Yu-Shan Hou; Chen-Xiao Wang
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.